CIK 0000925741
- Non-accelerated filer
- Smaller reporting company
BioCardia, Inc.
Sign in to watch- Ticker
- BCDA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 232753988
- Phone
- +1 650-226-0123
- Business address
- 320 SOQUEL WAY, SUNNYVALE, CA, 94085
- Former names
- Tiger X Medical, Inc., Cardo Medical, Inc., CLICKNSETTLE COM INC, NAM CORP
- 4 Open-market buy President and CEO bought 500 shares at an average $2.50 ($1,251)
- 4 Open-market buy Chief Financial Officer bought 1,600 shares at $2.56 ($4,102)
- 4 Open-market buy President and CEO bought 400 shares at $2.52 ($1,008)
- 4 Open-market buy Director bought 2,000 shares at $2.53 ($5,060)
- 4 Open-market buy President and CEO bought 300 shares at $2.55 ($765)
- 4 Open-market buy President and CEO bought 3,850 shares at an average $2.36 ($9,080)
- 4 Open-market buy Chief Financial Officer bought 500 shares at $2.64 ($1,318)
- 4 Open-market buy Director bought 1,000 shares at $2.70 ($2,700)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 14,277 shares (option exercise)
- 4 Exercise or conversion Director acquired 14,277 shares (option exercise)
- 4 Exercise or conversion Director acquired 14,277 shares (option exercise)
- 4 Exercise or conversion Director acquired 14,277 shares (option exercise)
- 4/A Open-market buy Director bought 5,000 shares at $1.50 ($7,500)
- 4 Open-market buy Chief Financial Officer bought 2,850 shares at $2.45 ($6,988)
- 4 Open-market buy Director bought 1,000 shares at $2.43 ($2,430)
- 4 Open-market buy President and CEO bought 1,100 shares at an average $1.74 ($1,914)
- 4 Open-market buy President and CEO bought 700 shares at an average $1.65 ($1,154)
Page 15 of 23 · 442 filings